source
- Labcorp posts higher Q2 earnings on strength of diagnostics, lab services; adjusts full-year guidanceLabcorp continues to power along as it posts strong quarterly earnings led by growth in its diagnostics and lab services and triggering the medtech to raise its full-year guidance.Fierce Biotech · 12h ago↗ source
- Takeda scraps another phase 2 celiac disease therapy, narrowing pipeline to oneTakeda has dropped another celiac disease therapy from its phase 2 pipeline, leaving the company with just one shot at treating the condition.Fierce Biotech · 13h ago↗ source
- GSK pens $110M biological datasets pact with AI biotech RelationGSK is boosting its AI chops with a new deal worth up to $110 million with Relation.